
Jagquin 64.5mg Injection
Marketer
Jagsonpal Pharmaceuticals Ltd
Salt Composition
Chloroquine (64.5mg)
Overview Jagquin 64.5mg Injection
Malarex 64.5mg Injection combats malaria parasites, preventing and treating the infection. Its mechanism involves eliminating the causative parasite, halting infection spread. Administration is strictly by a healthcare provider via injection; self-injection is prohibited. Mosquito bite prevention is crucial: apply insect repellent to exposed skin, spray indoor repellents, and wear light, covering clothing after dusk. Potential side effects include weakness, vomiting, rash, itching, abdominal pain, diarrhea, appetite loss, nausea, and injection site reactions (pain, swelling, redness). Persistent side effects warrant medical consultation. Diabetics should inform their physician, as the medication may lower blood sugar, requiring regular monitoring. Blurred vision may occur, necessitating regular eye exams. Long-term use may necessitate blood cell count monitoring. Report unexplained bruising, bleeding, sore throat, fever, or fatigue to your doctor immediately.
Primary Ingredients of Jagquin 64.5mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Jagquin 64.5mg Injection
Managing Malaria Infections
Major Benefits of Jagquin 64.5mg Injection:
The medication will be administered by your physician or their qualified staff; self-medication is strongly discouraged.
Common Side effects of Jagquin 64.5mg Injection:
- Weakness
- Rash
- Headache
- Dizziness
- Vomiting
- Nausea
- Stomach pain
- Loss of appetite
- Diarrhea
How to use Jagquin 64.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Jagquin 64.5mg Injection works:
Malaria is effectively combated by Jagquin 64.5mg Injection, an antiparasitic drug. Its mechanism involves elevating blood haem levels, a compound harmful to the malaria parasite. This heightened toxicity eradicates the parasite, halting the infection's progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Jagquin 64.5mg Injection and alcohol is unknown. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Jagquin 64.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Lactation compatibility studies indicate that a 64.5 mg Jagquin injection poses minimal risk during breastfeeding. Research in humans shows negligible drug transfer to breast milk, suggesting no significant infant harm.
DrivingUNSAFE
Administering Jagquin 64.5mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include blurred vision or impaired visual focus, potentially hindering safe driving.
KidneyCAUTION
For individuals with kidney impairment, the administration of a 64.5mg Jagquin injection requires careful consideration. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Jagquin 64.5mg Injection cautiously, potentially requiring dose modification. Physician consultation is recommended. Liver function should be regularly monitored during treatment.
What if you forget to take Jagquin 64.5mg Injection :
NA
Facts to Know About Jagquin 64.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoquinoline-4-derivative |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Aminoquinoline Antimalarials |
